A decade of proof-of-concept trials shows remyelination is achievable. The harder question, per a Cambridge neurologist's own assessment, is whether that biology will ever translate into measurable disability benefit.
Vertex Pharmaceuticals has presented the first clinical data for Casgevy in children ages 5-11 at the American Society of Hematology annual meeting, on December 6, 2025, in Orlando.
Epigenetics is the field of study focused on changes in DNA that do not involve alterations to the underlying sequence, per NHGRI's Talking Glossary, which also calls the field epigenomics.
Cell and gene therapy manufacturing produces either a viral vector carrying a therapeutic gene or living cells engineered with one, under good manufacturing practice controls.
Base editing and prime editing are precision genome editing methods that rewrite DNA without the double-strand break standard CRISPR cutting relies on.